התחייבויות שוטפות של החברה: Carmell Therapeutics Corporation (XAGE)

Longevity Health Holdings (XAGE) ensures the delivery of aesthetic preparations via specialized transport to preserve their properties. The stability of dermatological product supply is maintained through diversified hubs and long-term agreements. The business relies on complex patents and strict FDA oversight. The current figure is 0.00. The market trend below illustrates the dynamics of short-term debt obligations for the company providing high-tech medical services.

The premium status of Longevity Health Holdings (XAGE) and the operation of high-cost clinics require stable liquidity management to maintain operational resilience. Current liabilities with a maturity of up to one year at 0.00 measure the total obligations due within twelve months, allowing for an assessment of cash gap risks and the business's dependence on interest rate volatility when servicing its short-term credit portfolio.